The Medicines Company Case Analysis

Background

The Medicines Companys business model is to fuck off or lease products in the development stage from leading pharmaceutical companies. Essentially, they will acquire or lease drugs that have been abandoned or shelved due(p) to lack of early stage research results. The companys success lays on their being able to save rejected compounds, receive FDA laudation for their engage, and still turn a profit. This pillowcase study provides a look at the first few years of this start-up company, from the initial review of abandoned drugs to the release of their first drug Angiomax.

Angiomax is a direct competitor to Heparin, the leading anticoagulant used in the market. The company continued research on this drug, which was licensed from Biogen in 1997, and received approval for marketing in 2001 for use in coronary angioplasty procedures. The company continued working towards approval for the use of Angi0max in treating arterial thrombosis and other related conditions.

Problems

Analysis of the Medicines Company case revealed several critical aspects that need to be addressed. The pharmaceutical application can be truly profitable, but is also very tryy. As described in the case, bringing a parvenu drug to market is a costly and lengthy border requiring an average of 10 years.



Big Pharmaceutical companies struggle to sustain upcoming drugs in their pipeline to provide revenue when quick drugs come off patent and are replaced by generic wine compounds. With 1 in 4000 compounds making it to market, there is significant risk of failure that can be reduced by having legion(predicate) compounds in development. Additionally, a drug companys reputation can slowly be tarnished by safety issues with a compound, dramatically affect their sales.

Large pharmaceutical companies tend to focus on blockbuster drugs to light upon more profits so there may be compounds that are discarded because they hold smaller...

If you want to get a full essay, order it on our website: Ordercustompaper.com



If you want to get a full essay, wisit our page: write my paper